Record 2020 Total Product Bookings of $1+ billion Full Year 2020 Revenues of $892.2 million Ended Year with 145 Long-Term, Sole-Source Agreements with the Top 300 U.S. Health Systems Entered 2021 with Record Product Backlog of $924 million MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Feb....
Company Expects to Exceed Previously Announced Guidance Across All Key Metrics; Provides Full Year 2021 Guidance and Updates Long-Term Targets 2020 Total Product Bookings Expected to be Approximately $1.00 Billion and 2020 Revenues Expected to be $890 Million-$892 Million Increased Full Year 2021...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 15, 2020-- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences: Randall Lipps ,...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Nov. 6, 2020-- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences: Peter Kuipers , Omnicell...
GAAP and non-GAAP revenues of $213.7 million GAAP net income per diluted share of $0.20 Non-GAAP net income per diluted share of $0.60 MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Oct. 27, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for...
Expands pharmacy inventory management capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy , building on the recent launch of Omnicell One Expected to be immediately accretive to...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 29, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, October 27, 2020 , to discuss the Company’s Third Quarter...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 23, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced today the pricing of $500 million aggregate principal amount of 0.25% Convertible Senior...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 22, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that it intends to offer, subject to market conditions and other factors, $500.0...
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 1, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the following upcoming investor conferences: 2020 Wells Fargo Virtual Healthcare...